Breast Cancer News and Research

Latest Breast Cancer News and Research

Adeno-associated virus type 2 kills human breast cancer cells in lab

A nondisease-causing virus kills human breast cancer cells in the laboratory, creating opportunities for potential new cancer therapies, according to Penn State College of Medicine researchers who tested the virus on three different breast cancer types that represent the multiple stages of breast cancer development.

23 Sep 2011

USPTO issues patent for Lixte's LB-100 to treat cancer

John S. Kovach, M.D., Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc., announces that the United States Patent and Trademark Office awarded a patent on its lead compound, LB-100, as well as a number of structurally related compounds, which has shown promising anti-cancer activity.

23 Sep 2011

BPA found in kids’ canned food

The chemical Bisphenol A (BPA) that is suspected to be harmful to babies may be found in several child-friendly canned foods. Breast Cancer Fund researchers tested for bisphenol A (BPA) in six products specifically marketed to children. Included in the list were such popular kid-targeted meals as Campbell’s “Disney Princess" soup with "shaped pasta with chicken in chicken broth” and Annie’s Homegrown certified organic “Cheesy Ravioli.” BPA, which is found in plastics, cash-register receipts, dental sealants and even money, has been linked in animal studies to a host of health ills, including possible cancers and developmental problems and early puberty.

22 Sep 2011

Cambridge Heart enters agreement with EO Medical for MTWA technology

Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced that it has executed an exclusive agreement with EO Medical Pte Ltd to distribute its HearTwave II System and proprietary Microvolt T-Wave Alternans (MTWA) software and Micro-V Alternans Sensors in Singapore upon regulatory approval.

22 Sep 2011

MD Anderson professor wins 2011 Julie and Ben Rogers Award for Excellence in Prevention

Lorna McNeill, Ph.D., assistant professor in the Department of Health Disparities Research at The University of Texas MD Anderson Cancer Center, is the recipient of the 2011 Julie and Ben Rogers Award for Excellence in Prevention.

22 Sep 2011

Scientists identify stress receptor that stimulates growth and migration of cancer cells

It's a common belief that there's a link between chronic stress and an increased risk of cancer. In new research published online by the International Journal of Cancer, scientists at The University of Western Ontario have taken a step toward confirming that belief.

22 Sep 2011

Converting genetic data into biomedical knowledge a true challenge for statisticians

Within a decade, a combination of advanced measurement techniques and statistics will enable scientists to develop methods to diagnose serious diseases caused by genetic defects. Ten years after that, there may be medicines available to repair these defects.

21 Sep 2011

MRI screenings for breast cancer benefit high-risk, underserved women

Using breast magnetic resonance imaging (MRI) screenings among targeted, high-risk, underserved women significantly decreased diagnostic cost and increased patient compliance rates with follow-up compared to using general risk mammography screenings.

21 Sep 2011

Enrollment commences in Boehringer Ingelheim's TOviTO Phase III combination trial for COPD

Boehringer Ingelheim today announced enrolment has commenced in its TOviTO Phase III clinical trial program. It will investigate tiotropium plus olodaterol in a once-daily fixed-dose combination for the treatment of chronic obstructive pulmonary disease.

21 Sep 2011

Silence Therapeutics reports revenue of £354,078 for six months ended 30 June 2011

Silence Therapeutics Plc, a leading international RNAi therapeutics company, today provides a corporate update and announces its interim results for the six months ended 30 June 2011.

21 Sep 2011

Survey confirms low BPA exposure levels in food packaging

Today's supermarket survey of a handful of canned food products by the Breast Cancer Fund offers further confirmation that only a very small amount of bisphenol A (BPA) is found in food packaging, and those levels are well within the safety recommendations of government agencies.

21 Sep 2011

Scientists discover crucial connection in skin formation

Skin is the body's armor, protecting us from disease agents, injury, excessive water loss, and cold and heat. Yet mutations in a single gene, the gene for the protein p63, cause numerous diseases and malformations of the uppermost layer of skin - the epidermis - and other tissues. In the epidermis, these range from skin cancers to dysplasias that cause cracking, bleeding, infection, and discoloration.

21 Sep 2011

Regulatory bias against taking oral anti-cancer medications with food places patients at risk of overdose

A regulatory bias against taking oral anti-cancer medications with food places many patients at increased risk for an overdose and forces them to "flush costly medicines down the toilet," argues Mark Ratain, MD, an authority on cancer-drug dosing.

20 Sep 2011

New research has potential to alleviate side effects of cancer treatments

Beth Faiman MSN, CNP, a doctoral candidate at the Frances Payne Bolton School of Nursing at Case Western Reserve University, is studying whether an over-the-counter medication could ease chemotherapy side effects for people with blood and bone marrow cancers.

20 Sep 2011

FoxM1 protein plays a critical role in development of medulloblastomas

Medulloblastomas constitute the most frequent class of malignant childhood brain tumor. Tumors of this type arise due to the uncontrolled proliferation of immature nerve cells in the developing brain, and there is no targeted treatment available.

20 Sep 2011

Preclinical studies shows EmPAC more effective than Taxol

Cornerstone Pharmaceuticals, Inc. has announced the publication of data from preclinical studies on EmPAC™, its nanoparticle reformulation of paclitaxel, in the August issue of the Journal of Nanoscience and Nanotechnology. The publication highlights data demonstrating improved safety and efficacy of EmPAC™ versus Taxol®, the generic formulation of paclitaxel and one of the most widely prescribed chemotherapies. EmPAC™ is a nanoemulsion formulation of Paclitaxel and is the lead product candidate of Cornerstone’s proprietary Emulsiphan™ cancer selective delivery nanotechnology platform. Taxol®, an injectable formulation of Paclitaxel, is currently used to treat a variety of cancers, including ovarian carcinomas, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi’s sarcoma.

19 Sep 2011

Amgen's Prolia receives FDA approval for new indications to treat cancer patients

Amgen today announced that the U.S. Food and Drug Administration (FDA) approved two new indications for Prolia® (denosumab) as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer and as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer.

19 Sep 2011

Top-line data from Spectrum's SPI-1620 Phase 1 combination study on carcinoma

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that top-line data from part one of a two-part Phase 1 study of SPI-1620 in combination with docetaxel was presented in an oral presentation at the 12th International Conference on Endothelin, held in Cambridge, United Kingdom, from September 11-14, 2011. Part one of the study has been completed, while part two is ongoing.

19 Sep 2011

ESMO honors three medical oncologists for cancer care and research

The European Society for Medical Oncology (ESMO) has honored three of Europe's leading medical oncologists with prestigious awards recognizing their achievements in clinical care and research.

19 Sep 2011

Roundup: San Diego launches new HIV testing effort; Study finds economy hurt by Mass. health law; Texas schools turning to safe sex curriculum

The Centers for Disease Control says 20 percent of Americans with HIV don't know they're infected, and those people are responsible for about half of all new infections. A new effort in San Diego is trying to reduce those numbers by making HIV testing more widespread.

17 Sep 2011

Breast Cancer News and Research

Latest Breast Cancer News and Research

Adeno-associated virus type 2 kills human breast cancer cells in lab

USPTO issues patent for Lixte's LB-100 to treat cancer

BPA found in kids’ canned food

Cambridge Heart enters agreement with EO Medical for MTWA technology

MD Anderson professor wins 2011 Julie and Ben Rogers Award for Excellence in Prevention

Scientists identify stress receptor that stimulates growth and migration of cancer cells

Converting genetic data into biomedical knowledge a true challenge for statisticians

MRI screenings for breast cancer benefit high-risk, underserved women

Enrollment commences in Boehringer Ingelheim's TOviTO Phase III combination trial for COPD

Silence Therapeutics reports revenue of £354,078 for six months ended 30 June 2011

Survey confirms low BPA exposure levels in food packaging

Scientists discover crucial connection in skin formation

Regulatory bias against taking oral anti-cancer medications with food places patients at risk of overdose

New research has potential to alleviate side effects of cancer treatments

FoxM1 protein plays a critical role in development of medulloblastomas

Preclinical studies shows EmPAC more effective than Taxol

Amgen's Prolia receives FDA approval for new indications to treat cancer patients

Top-line data from Spectrum's SPI-1620 Phase 1 combination study on carcinoma

ESMO honors three medical oncologists for cancer care and research

Roundup: San Diego launches new HIV testing effort; Study finds economy hurt by Mass. health law; Texas schools turning to safe sex curriculum

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in